# Chemoradiotherapy of NSCLC Stage IIIB

> **NCT00198432** · PHASE2 · COMPLETED · sponsor: **Intergroupe Francophone de Cancerologie Thoracique** · enrollment: 130 (—)

## Conditions studied

- NSCLC Stage IIIB
- Concomitant Radiochemotherapy

## Interventions

- **DRUG:** Paclitaxel, vinorelbine, cisplatin

## Key facts

- **NCT ID:** NCT00198432
- **Lead sponsor:** Intergroupe Francophone de Cancerologie Thoracique
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 130 (—)
- **Last updated:** 2016-03-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198432, "Chemoradiotherapy of NSCLC Stage IIIB". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00198432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*